| Core engagement with β-arrestin is dispensable for agonist-induced vasopressin receptor endocytosis and ERK activation P Kumari, A Srivastava, E Ghosh, R Ranjan, S Dogra, PN Yadav, ... Molecular Biology of the Cell 28 (8), 1003-1010, 2017 | 103 | 2017 |
| Biased agonism at kappa opioid receptors: Implication in pain and mood disorders S Dogra, PN Yadav European journal of pharmacology 763, 184-190, 2015 | 54 | 2015 |
| Metabotropic glutamate receptors as emerging targets for the treatment of schizophrenia S Dogra, PJ Conn Molecular pharmacology 101 (5), 275-285, 2022 | 46 | 2022 |
| Docosahexaenoic acid modulates brain-derived neurotrophic factor via GPR40 in the brain and alleviates diabesity-associated learning and memory deficits in mice C Sona, A Kumar, S Dogra, BA Kumar, D Umrao, PN Yadav Neurobiology of Disease 118, 94-107, 2018 | 46 | 2018 |
| A synthetic intrabody-based selective and generic inhibitor of GPCR endocytosis E Ghosh, A Srivastava, M Baidya, P Kumari, H Dwivedi, K Nidhi, R Ranjan, ... Nature Nanotechnology 12 (12), 1190-1198, 2017 | 41 | 2017 |
| Acute restraint stress redirects prefrontal cortex circuit function through mGlu5 receptor plasticity on somatostatin-expressing interneurons ME Joffe, J Maksymetz, JR Luschinger, S Dogra, AS Ferranti, DJ Luessen, ... Neuron 110 (6), 1068-1083. e5, 2022 | 39 | 2022 |
| Targeting metabotropic glutamate receptors for the treatment of depression and other stress-related disorders S Dogra, PJ Conn Neuropharmacology 196, 108687, 2021 | 37 | 2021 |
| Activating mGlu3 metabotropic glutamate receptors rescues schizophrenia-like cognitive deficits through metaplastic adaptations within the hippocampus S Dogra, BJ Stansley, Z Xiang, W Qian, RG Gogliotti, F Nicoletti, ... Biological psychiatry 90 (6), 385-398, 2021 | 33 | 2021 |
| Tango assay for ligand-induced GPCR–β-arrestin2 interaction: Application in drug discovery S Dogra, C Sona, A Kumar, PN Yadav Methods in Cell Biology 132, 233-254, 2016 | 30 | 2016 |
| Chronic kappa opioid receptor activation modulates NR2B: implication in treatment resistant depression S Dogra, A Kumar, D Umrao, AA Sahasrabuddhe, PN Yadav Scientific reports 6 (1), 33401, 2016 | 24 | 2016 |
| Epidermal growth factor receptor inhibitor cancer drug gefitinib modulates cell growth and differentiation of acute myeloid leukemia cells via histamine receptors M Yadav, AK Singh, H Kumar, G Rao, B Chakravarti, A Gurjar, S Dogra, ... Biochimica et Biophysica Acta (BBA)-General Subjects 1860 (10), 2178-2190, 2016 | 19 | 2016 |
| Epigenetic regulation of G protein coupled receptor signaling and its implications in psychiatric disorders S Dogra, C Sona, A Kumar, PN Yadav The International Journal of Biochemistry & Cell Biology 77, 226-239, 2016 | 19 | 2016 |
| Chronic histamine 3 receptor antagonism alleviates depression like conditions in mice via modulation of brain-derived neurotrophic factor and hypothalamus-pituitary adrenal axis A Kumar, S Dogra, C Sona, D Umrao, M Rashid, SK Singh, M Wahajuddin, ... Psychoneuroendocrinology 101, 128-137, 2019 | 17 | 2019 |
| Novel tetrahydroquinazolinamines as selective histamine 3 receptor antagonists for the treatment of obesity A Kumar, VR Pasam, RK Thakur, M Singh, K Singh, M Shukla, A Yadav, ... Journal of Medicinal Chemistry 62 (9), 4638-4655, 2019 | 13 | 2019 |
| Discovery of an isocoumarin analogue that modulates neuronal functions via neurotrophin receptor TrkB K Sudarshan, A kumar Boda, S Dogra, I Bose, PN Yadav, IS Aidhen Bioorganic & Medicinal Chemistry Letters 29 (4), 585-590, 2019 | 11 | 2019 |
| Frontal cortex genetic ablation of metabotropic glutamate receptor subtype 3 (mGlu3) impairs postsynaptic plasticity and modulates affective behaviors ME Joffe, CI Santiago, SAD Vermudez, NM Fisher, S Dogra, ... Neuropsychopharmacology 46 (12), 2148-2157, 2021 | 10 | 2021 |
| Discovery of Novel Muscarinic Receptor Modulators by Integrating a Natural Product Framework and a Bioactive Molecule R Varkhedkar, S Dogra, D Tiwari, Y Hussain, PN Yadav, G Pandey ChemMedChem 13 (4), 384-395, 2018 | 9 | 2018 |
| GPCR interactions involving metabotropic glutamate receptors and their relevance to the pathophysiology and treatment of CNS disorders F Nicoletti, L Di Menna, L Iacovelli, R Orlando, AR Zuena, PJ Conn, ... Neuropharmacology, 109569, 2023 | 8 | 2023 |
| Differential activity of mGlu7 allosteric modulators provides evidence for mGlu7/8 heterodimers at hippocampal Schaffer collateral-CA1 synapses X Lin, NM Fisher, S Dogra, RK Senter, CW Reed, JJ Kalbfleisch, ... Journal of Biological Chemistry 298 (10), 2022 | 8 | 2022 |
| Metabotropic glutamate receptor 3 as a potential therapeutic target for psychiatric and neurological disorders S Dogra, J Putnam, PJ Conn Pharmacology Biochemistry and Behavior 221, 173493, 2022 | 7 | 2022 |
